← Back to all trials
Recruiting
NCT05708443
Effect of Combined Endurance Training on ADL and Walking in COPD Patients
Conditions: COPD
Sex: All
Phase: NA
Enrollment: 36
Sponsor: Istituti Clinici Scientifici Maugeri SpA
Location: Italy
Summary
Chronic Obstructive Pulmonary Disease (COPD) is a chronic disease with related exercise intolerance and marked disability due to symptoms such as dyspnea and fatigue.
Effort intolerance and exercise-induced symptoms cause marked impairment in completing activities of daily living (ADL).
Pulmonary rehabilitation (PR), which has exercise as a major component, is considered a key treatment in the management of COPD since PR is effective in improving exercise tolerance, exercise-induced dyspnea and fatigue, and health-related quality of life.
Rehabilitation is also effective in improving the time required to perform ADLs, reducing symptoms and disability.
Studies show that rehabilitation protocols with upper limb exercises added to lower limb training are able to give additional benefits in terms of effort tolerance (endurance time at the arm ergometer and oxygen consumption) and reduction of dyspnea at iso-load.The primary aim of this study is to evaluate whether the combined "arm and leg" training modality, compared to a gold standard protocol -involving only the lower limbs training- is more effective in improving ADL performance in terms of reduction of exercise time for a specific test (GLITTRE test).
Eligibility Criteria
Inclusion Criteria:GOLD class 2-3 COPDForced Expiratory Volume in the first second (FEV1) between 30% and 70% of the predicted valueability to walk and climb stairs without assistancestable clinical condition (pH > 7.35)Exclusion Criteria:chronic respiratory insufficiency on long-term oxygen therapy (LTOT)severe orthopedic, neurological or cardiological comorbiditiescognitive impairmentrecent exacerbation (within 15 days) requiring a change in therapypresence of lung disease other than COPDterminality
Source: ClinicalTrials.gov (NCT05708443). StuddyBuddy aggregates publicly available trial information.